Literature DB >> 18158249

Synthesis of beta- and gamma-oxa isosteres of fosmidomycin and FR900098 as antimalarial candidates.

Timothy Haemers1, Jochen Wiesner, Dirk Giessmann, Thomas Verbrugghen, Ulrik Hillaert, Regina Ortmann, Hassan Jomaa, Andreas Link, Martin Schlitzer, Serge Van Calenbergh.   

Abstract

To expand the structure-activity relationships of fosmidomycin and FR900098, two potent antimalarials interfering with the MEP-pathway, we decided to replace a methylene group in beta-position of the phosphonate moiety of these leads by an oxygen atom. beta-oxa-FR900098 (11) proved equally active as the parent compound. When applied to 4-[hydroxyl(methyl)amino]-4-oxobutyl phosphonic acid, featuring a hydroxamate instead of the retrohydroxamate moiety, a beta-oxa modification yielded a derivative (13) with superior activity against the Plasmodium falciparum 3D7 strain than fosmidomycin, while a gamma-oxa modification resulted in less active derivatives. A bis(pivaloyloxymethyl)ester of phosphonate 13 proved twice as active in inhibiting cultured parasites as a similar prodrug of FR900098.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18158249     DOI: 10.1016/j.bmc.2007.12.001

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  12 in total

1.  A closer look at the spectroscopic properties of possible reaction intermediates in wild-type and mutant (E)-4-hydroxy-3-methylbut-2-enyl diphosphate reductase.

Authors:  Weiya Xu; Nicholas S Lees; Dominique Hall; Dhanushi Welideniya; Brian M Hoffman; Evert C Duin
Journal:  Biochemistry       Date:  2012-06-07       Impact factor: 3.162

Review 2.  Prodrugs of phosphonates and phosphates: crossing the membrane barrier.

Authors:  Andrew J Wiemer; David F Wiemer
Journal:  Top Curr Chem       Date:  2015

3.  Resistance to the antimicrobial agent fosmidomycin and an FR900098 prodrug through mutations in the deoxyxylulose phosphate reductoisomerase gene (dxr).

Authors:  Christopher M Armstrong; David J Meyers; Leah S Imlay; Caren Freel Meyers; Audrey R Odom
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

4.  Antibacterial and antitubercular activity of fosmidomycin, FR900098, and their lipophilic analogs.

Authors:  Eugene Uh; Emily R Jackson; Géraldine San Jose; Marcus Maddox; Robin E Lee; Richard E Lee; Helena I Boshoff; Cynthia S Dowd
Journal:  Bioorg Med Chem Lett       Date:  2011-10-05       Impact factor: 2.823

5.  A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling.

Authors:  Baichen Zhang; Kristin M Watts; Dana Hodge; Lisa M Kemp; David A Hunstad; Leslie M Hicks; Audrey R Odom
Journal:  Biochemistry       Date:  2011-04-11       Impact factor: 3.162

6.  Functional genetic analysis of the Plasmodium falciparum deoxyxylulose 5-phosphate reductoisomerase gene.

Authors:  Audrey R Odom; Wesley C Van Voorhis
Journal:  Mol Biochem Parasitol       Date:  2009-12-16       Impact factor: 1.759

7.  Structure-Activity Relationships of the MEPicides: N-Acyl and O-Linked Analogs of FR900098 as Inhibitors of Dxr from Mycobacterium tuberculosis and Yersinia pestis.

Authors:  Géraldine San Jose; Emily R Jackson; Amanda Haymond; Chinchu Johny; Rachel L Edwards; Xu Wang; R Carl Brothers; Emma K Edelstein; Audrey R Odom; Helena I Boshoff; Robin D Couch; Cynthia S Dowd
Journal:  ACS Infect Dis       Date:  2016-10-12       Impact factor: 5.084

8.  Molecular basis of fosmidomycin's action on the human malaria parasite Plasmodium falciparum.

Authors:  Tomonobu Umeda; Nobutada Tanaka; Yoshio Kusakabe; Masayuki Nakanishi; Yukio Kitade; Kazuo T Nakamura
Journal:  Sci Rep       Date:  2011-06-14       Impact factor: 4.379

9.  Lipophilic prodrugs of FR900098 are antimicrobial against Francisella novicida in vivo and in vitro and show GlpT independent efficacy.

Authors:  Elizabeth S McKenney; Michelle Sargent; Hameed Khan; Eugene Uh; Emily R Jackson; Géraldine San Jose; Robin D Couch; Cynthia S Dowd; Monique L van Hoek
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

10.  Hydroperoxylation by hydroxyethylphosphonate dioxygenase.

Authors:  John T Whitteck; Robert M Cicchillo; Wilfred A van der Donk
Journal:  J Am Chem Soc       Date:  2009-11-11       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.